NUS logo

Nu Skin Enterprises (NUS) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$256.06 M
-$8.67 M-3.27%

31 December 2023

NUS Cash And Cash Equivalents Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Cash And Cash Equivalents

$227.75 M
+$3.50 M+1.56%

30 September 2024

NUS Quarterly Cash And Cash Equivalents Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NUS Cash And Cash Equivalents Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-3.3%-2.4%
3 y3 years-36.4%-19.4%
5 y5 years-33.8%-28.8%

NUS Cash And Cash Equivalents High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-36.4%at low-37.4%+7.2%
5 y5 years-36.4%at low-43.4%+7.2%
alltimeall time-51.2%+305.1%-58.9%+587.4%

Nu Skin Enterprises Cash And Cash Equivalents History

DateAnnualQuarterly
Sept 2024
-
$227.75 M(+1.6%)
June 2024
-
$224.25 M(+5.5%)
Mar 2024
-
$212.53 M(-17.0%)
Dec 2023
$256.06 M(-3.3%)
$256.06 M(+9.7%)
Sept 2023
-
$233.31 M(-1.0%)
June 2023
-
$235.55 M(+2.4%)
Mar 2023
-
$229.94 M(-13.1%)
Dec 2022
$264.73 M(-22.0%)
$264.73 M(-10.0%)
Sept 2022
-
$294.14 M(-19.2%)
June 2022
-
$363.92 M(+20.4%)
Mar 2022
-
$302.22 M(-11.0%)
Dec 2021
$339.59 M(-15.7%)
$339.59 M(+20.2%)
Sept 2021
-
$282.41 M(-20.4%)
June 2021
-
$354.76 M(+4.6%)
Mar 2021
-
$339.10 M(-15.8%)
Dec 2020
$402.68 M(+20.0%)
$402.68 M(+9.8%)
Sept 2020
-
$366.71 M(-2.3%)
June 2020
-
$375.51 M(+6.5%)
Mar 2020
-
$352.58 M(+5.0%)
Dec 2019
$335.63 M(-13.3%)
$335.63 M(+4.9%)
Sept 2019
-
$320.03 M(-11.3%)
June 2019
-
$360.63 M(+16.2%)
Mar 2019
-
$310.29 M(-19.8%)
Dec 2018
$386.91 M(-9.3%)
$386.91 M(-0.8%)
Sept 2018
-
$390.07 M(-3.0%)
June 2018
-
$402.03 M(-4.6%)
Mar 2018
-
$421.48 M(-1.2%)
Dec 2017
$426.40 M(+19.4%)
$426.40 M(+17.2%)
Sept 2017
-
$363.77 M(+5.4%)
June 2017
-
$345.10 M(+2.8%)
Mar 2017
-
$335.58 M(-6.1%)
Dec 2016
$357.25 M(+23.5%)
$357.25 M(-30.9%)
Sept 2016
-
$516.99 M(-5.1%)
June 2016
-
$544.85 M(+117.9%)
Mar 2016
-
$250.09 M(-13.6%)
Dec 2015
$289.35 M(+0.3%)
$289.35 M(-5.4%)
Sept 2015
-
$305.81 M(+4.6%)
June 2015
-
$292.41 M(-4.0%)
Mar 2015
-
$304.71 M(+5.7%)
Dec 2014
$288.42 M(-45.1%)
$288.42 M(+47.9%)
Sept 2014
-
$194.94 M(-11.2%)
June 2014
-
$219.50 M(-22.9%)
Mar 2014
-
$284.58 M(-45.8%)
Dec 2013
$525.15 M(+64.1%)
$525.15 M(-5.1%)
Sept 2013
-
$553.50 M(+37.5%)
June 2013
-
$402.68 M(+23.6%)
Mar 2013
-
$325.72 M(+1.8%)
Dec 2012
$320.02 M(+17.2%)
$320.02 M(-0.6%)
Sept 2012
-
$321.93 M(-13.4%)
June 2012
-
$371.80 M(+34.6%)
Mar 2012
-
$276.21 M(+1.2%)
Dec 2011
$272.97 M(+18.5%)
$272.97 M(+12.8%)
Sept 2011
-
$242.03 M(+3.7%)
June 2011
-
$233.40 M(+8.1%)
Mar 2011
-
$215.94 M(-6.2%)
Dec 2010
$230.34 M
$230.34 M(+16.6%)
DateAnnualQuarterly
Sept 2010
-
$197.63 M(+14.5%)
June 2010
-
$172.67 M(-4.1%)
Mar 2010
-
$180.14 M(+14.0%)
Dec 2009
$158.04 M(+37.9%)
$158.04 M(-1.6%)
Sept 2009
-
$160.64 M(+28.2%)
June 2009
-
$125.30 M(+7.1%)
Mar 2009
-
$117.03 M(+2.1%)
Dec 2008
$114.59 M(+31.2%)
$114.59 M(+13.1%)
Sept 2008
-
$101.28 M(+9.4%)
June 2008
-
$92.56 M(-5.1%)
Mar 2008
-
$97.54 M(+11.7%)
Dec 2007
$87.33 M(-28.0%)
$87.33 M(-26.0%)
Sept 2007
-
$118.02 M(+19.2%)
June 2007
-
$99.01 M(-1.8%)
Mar 2007
-
$100.81 M(-16.9%)
Dec 2006
$121.35 M(-21.9%)
$121.35 M(+2.6%)
Sept 2006
-
$118.29 M(-2.7%)
June 2006
-
$121.55 M(-6.3%)
Mar 2006
-
$129.77 M(-16.5%)
Dec 2005
$155.41 M(+41.5%)
$155.41 M(+1.7%)
Sept 2005
-
$152.81 M(+0.8%)
June 2005
-
$151.64 M(+0.6%)
Mar 2005
-
$150.80 M(+37.3%)
Dec 2004
$109.86 M(-10.4%)
$109.86 M(-11.1%)
Sept 2004
-
$123.60 M(-27.2%)
June 2004
-
$169.77 M(+25.4%)
Mar 2004
-
$135.36 M(+10.4%)
Dec 2003
$122.57 M(+1.9%)
$122.57 M(-15.1%)
Sept 2003
-
$144.44 M(+27.1%)
June 2003
-
$113.65 M(+9.4%)
Mar 2003
-
$103.87 M(-13.7%)
Dec 2002
$120.34 M(+58.5%)
$120.34 M(+14.2%)
Sept 2002
-
$105.41 M(+10.9%)
June 2002
-
$95.06 M(+28.8%)
Mar 2002
-
$73.80 M(-2.8%)
Dec 2001
$75.92 M(+18.6%)
$75.92 M(+15.3%)
Sept 2001
-
$65.87 M(+7.4%)
June 2001
-
$61.31 M(+19.0%)
Mar 2001
-
$51.54 M(-19.5%)
Dec 2000
$64.00 M(-41.9%)
$64.00 M(+28.3%)
Sept 2000
-
$49.90 M(+3.9%)
June 2000
-
$48.01 M(+44.9%)
Mar 2000
-
$33.13 M(-69.9%)
Dec 1999
$110.20 M(-41.6%)
$110.20 M(+1.8%)
Sept 1999
-
$108.20 M(-26.3%)
June 1999
-
$146.80 M(-8.3%)
Mar 1999
-
$160.00 M(-15.3%)
Dec 1998
$188.80 M(+8.3%)
$188.80 M(+8.3%)
Sept 1998
-
$174.30 M(+11.6%)
June 1998
-
$156.20 M(-1.8%)
Mar 1998
-
$159.10 M(-8.7%)
Dec 1997
$174.30 M(-15.8%)
$174.30 M(+13.0%)
Sept 1997
-
$154.20 M(+1.8%)
June 1997
-
$151.40 M(-23.1%)
Mar 1997
-
$196.80 M(-5.0%)
Dec 1996
$207.10 M(+227.7%)
$207.10 M(+227.7%)
Dec 1995
$63.20 M
$63.20 M

FAQ

  • What is Nu Skin Enterprises annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Nu Skin Enterprises?
  • What is Nu Skin Enterprises annual cash & cash equivalents year-on-year change?
  • What is Nu Skin Enterprises quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Nu Skin Enterprises?
  • What is Nu Skin Enterprises quarterly cash and cash equivalents year-on-year change?

What is Nu Skin Enterprises annual cash & cash equivalents?

The current annual cash & cash equivalents of NUS is $256.06 M

What is the all time high annual cash & cash equivalents for Nu Skin Enterprises?

Nu Skin Enterprises all-time high annual cash & cash equivalents is $525.15 M

What is Nu Skin Enterprises annual cash & cash equivalents year-on-year change?

Over the past year, NUS annual cash & cash equivalents has changed by -$8.67 M (-3.27%)

What is Nu Skin Enterprises quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of NUS is $227.75 M

What is the all time high quarterly cash and cash equivalents for Nu Skin Enterprises?

Nu Skin Enterprises all-time high quarterly cash and cash equivalents is $553.50 M

What is Nu Skin Enterprises quarterly cash and cash equivalents year-on-year change?

Over the past year, NUS quarterly cash and cash equivalents has changed by -$5.56 M (-2.38%)